Category: Licensing/Collaboration Deal Region: North America · United States Company: Amgen Inc

LegoChem Biosciences and Amgen Enter into a Multi Target Research Collaboration and License Agreement for the Development of Antibody Drug Conjugates

By, Admin 1 min read
Share
LegoChem Biosciences and Amgen Enter into a Multi Target Research Collaboration and License Agreement for the Development of Antibody Drug Conjugates
LCB Grants Amgen Rights to Research, Develop, and Commercialize Antibody-Drug Conjugates Combining Targets Selected by Amgen with LCB

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!